Tykerb 250 Mg
Tykerb 250 Mg is a cancer medication used together with another medicine called capecitabine (Xeloda) to treat a certain type of advanced breast cancer that has spread to other parts of the body, and is usually given after other cancer medications have been tried without successful treatment of symptoms.
Drug = Lapatinib
Strength = 250 Mg
Manufacturer = Glaxo SmithKline Pharmaceuticals Ltd
How To Take
Take Tykerb 250 Mg in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tykerb 250 Mg is to be taken empty stomach.
Tykerb 250 Mg
Decreased appetite or loss of appetite
Difficulty in breathing
Back pain or Joint pain
Clay colored stools
Fast or irregular heartbeat
Yellow eyes or skin
Nausea or vomiting
Before taking Tykerb 250 Mg, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
Before using this medication, tell your doctor or pharmacist your medical history, especially of: heart disease (e.g., irregular heartbeat), liver disease.
Tykerb 250 Mg may cause a condition that affects the heart rhythm (QT prolongation). QT prolongation can rarely cause serious (rarely fatal) fast/irregular heartbeat and other symptoms (such as severe dizziness, fainting) that need medical attention right away.
The risk of QT prolongation may be increased if you have certain medical conditions or are taking other drugs that may cause QT prolongation. Before using Tykerb 250 Mg, tell your doctor or pharmacist of all the drugs you take and if you have any of the following conditions: certain heart problems (heart failure, slow heartbeat, QT prolongation in the EKG), family history of certain heart problems (QT prolongation in the EKG, sudden cardiac death).
Tykerb 250 Mg is used together with another medication (capecitabine) to treat a certain type of breast cancer (HER2-positive) that has not responded to the standard treatment. Lapatinib may also be used together with another medication (letrozole) to treat HER2-positive breast cancer in women after menopause. It works by slowing or stopping the growth of cancer cells.